← Leaderboards
Brian B. Gowen
University Of California Los Angeles
$3,198,237
Attributed
$4,397,348
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $767.6K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,397,348 · 4
By mechanism
R01$2,252,222 · 1
U54$1,637,403 · 1
R21$361,723 · 1
R03$146,000 · 1
Top collaborators
- Manuel L Penichet3 shared
- Zhongde Wang2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Z Hong Zhou$29,087,466
- Manuel L Penichet$9,583,462
- Koki Morizono$5,593,709
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionJunin VirusViral Load ResultVirusViral Hemorrhagic FeversDrug KineticsNonhuman PrimateBolivian Hemorrhagic Fever VirusAntiviral TherapyAdvanced DevelopmentViralSuccessResearch Project GrantsBaseAntiviral AgentsPathogenicitySyndromeNational SecurityPreventTfrc GeneArenavirusReceptorBiodistributionLife
Grant awards (12)
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever$731,002
R01 · FY2025 · AI
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever$753,610
R01 · FY2024 · AI
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever$767,610
R01 · FY2023 · AI
Receptor-directed small-molecule inhibitors of New World hemorrhagic fever mammarenavirus entry$201,490
R21 · FY2022 · AI · contact PI
Human TfR1-expressing hamsters to model New World arenaviral hemorrhagic fever$73,000
R03 · FY2022 · AI · contact PI
Receptor-directed small-molecule inhibitors of New World hemorrhagic fever mammarenavirus entry$160,233
R21 · FY2021 · AI · contact PI
Human TfR1-expressing hamsters to model New World arenaviral hemorrhagic fever$73,000
R03 · FY2021 · AI · contact PI
T-705 Pyrazine derivative treatment of highly pathogenic arenaviral infections$321,257
U54 · FY2013 · AI · contact PI
T-705 Pyrazine derivative treatment of highly pathogenic arenaviral infections$323,515
U54 · FY2012 · AI · contact PI
T-705 Pyrazine derivative treatment of highly pathogenic arenaviral infections$313,234
U54 · FY2011 · AI · contact PI
T-705 Pyrazine derivative treatment of highly pathogenic arenaviral infections$369,078
U54 · FY2010 · AI · contact PI
T-705 Pyrazine derivative treatment of highly pathogenic arenaviral infections$310,319
U54 · FY2009 · AI · contact PI